Ultra Market Research | Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market
Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market
Report ID : 852
Category : Pharmaceuticals,Global
No Of Pages : 165
Published on: November 2024
Status: Published
Format :
Key Question Answer
Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players financial performance.
Evaluate strategies adopted by major players.
Recommendations
Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market
Introduction
The global ATTR-CM market encompasses the diagnosis, treatment, and management of transthyretin amyloid cardiomyopathy, a progressive and life-threatening disease caused by misfolded transthyretin proteins depositing in heart tissue. ATTR-CM is primarily classified into hereditary (hATTR) and wild-type (wtATTR) forms, affecting cardiac function. The growing awareness of this rare condition and advancements in diagnostic tools and therapeutics have significantly impacted the market's growth. Key applications include ATTR-CM drug development, targeted therapies, and cardiac imaging techniques. With increased prevalence, particularly among aging populations, and expanded research into amyloidosis solutions, the global ATTR-CM market is forecast to grow substantially. Recent market trends indicate a rise in the development of novel therapies and an active drug pipeline, positioning the market for significant expansion.
Segmentation
By Treatment Type
Pharmacological Therapies
Tafamidis
Diflunisal
Non-steroidal anti-inflammatory Drugs (NSAIDs)
Others
Gene Silencing Therapies
Patisiran
Inotersen
Supportive Therapies
Beta-Blockers
Diuretics
Anti-arrhythmic Drugs
By Diagnostics
Imaging Techniques
Echocardiography
Cardiac MRI
Nuclear Imaging
Others
Biomarker Testing
NT-proBNP Testing
Troponin Testing
Others
Genetic Testing
Mutation Analysis
Family History Testing
By End-User
Hospitals and Clinics
Cardiology Departments
Specialty Clinics
Diagnostic Laboratories
Independent Laboratories
Hospital-Affiliated Labs
Research and Academic Institutes
By Distribution Channel
Hospital Pharmacies
Inpatient Dispensing
Specialty Drug Distribution
Retail Pharmacies
Chain Pharmacies
Standalone Pharmacies
Online Pharmacies
By Geography
North America United States Canada
Europe Germany France United Kingdom
Rest of Europe
Asia Pacific China Japan India
Southeast Asia Rest of Asia Pacific
Latin America Brazil Rest of Latin America
Middle East & Africa (MEA) GCC North Africa South Africa Rest of Middle East & Africa
List of Market Players
Pfizer Inc. (United States)
Alnylam Pharmaceuticals (United States)
Eidos Therapeutics (United States)
Ionis Pharmaceuticals (United States)
BridgeBio Pharma (United States)
AstraZeneca (United Kingdom)
GlaxoSmithKline (United Kingdom)
Johnson & Johnson (United States)
Novartis AG (Switzerland)
Sanofi (France)
Prothena Corporation (United States)
Regeneron Pharmaceuticals (United States)
Merck & Co. (United States)
Amgen Inc. (United States)
Bristol-Myers Squibb (United States)
Drivers
The global ATTR-CM market is driven by increasing disease awareness, advancements in diagnostic capabilities, and a robust drug pipeline. Early detection of ATTR-CM through imaging techniques and biomarker testing has become a critical factor in improving patient outcomes, driving market demand for advanced diagnostic tools. The aging population, particularly in developed regions, has contributed to a rise in ATTR-CM prevalence, creating a strong need for effective treatment solutions. Pharmaceutical companies are actively investing in research to develop innovative therapies targeting transthyretin stabilization and gene silencing. Additionally, collaborations between research institutes and industry stakeholders have accelerated drug approvals, further fueling market growth.
Restraints
Despite significant progress, the ATTR-CM market faces challenges, including the high cost of therapies and limited accessibility to diagnostic tools in low-income regions. Many patients remain undiagnosed due to the disease's rarity and overlapping symptoms with other cardiac conditions, delaying appropriate treatment. Regulatory hurdles and lengthy approval processes for novel drugs also restrict market growth. Limited awareness among healthcare providers about the latest diagnostic and therapeutic advancements compounds these challenges.
Opportunity
The ATTR-CM market holds substantial growth potential, particularly in emerging economies where improved healthcare infrastructure can facilitate earlier diagnoses and treatment. Innovations in gene editing and RNA-based therapies offer promising opportunities to address the underlying genetic causes of hATTR. The growing use of artificial intelligence in cardiac imaging and biomarker analysis can enhance diagnostic accuracy, creating avenues for market expansion. Additionally, pharmaceutical companies are exploring combination therapies and expanding their focus on precision medicine, tailored to individual patient profiles, further driving the market forward.
Trend
The ATTR-CM market is witnessing a surge in gene silencing technologies such as RNA interference (RNAi) and antisense oligonucleotides, transforming the treatment landscape. AI integration in diagnostics is enabling more precise detection of ATTR-CM through advanced imaging analytics. Collaboration between biotech firms and research institutions is accelerating innovation in transthyretin amyloidosis therapies. The rise of telemedicine platforms is also facilitating early consultations and screenings, particularly in remote areas.
Transthyretin amyloid cardiomyopathy is a condition caused by the accumulation of misfolded transthyretin protein in the heart.
Rising disease prevalence, advancements in diagnostics, and innovative therapeutic development.
Cardiac imaging (MRI, echocardiography), biomarker tests, and genetic testing.
Pfizer, Alnylam Pharmaceuticals, and Eidos Therapeutics are among the market leaders.
Gene silencing therapies, AI-enabled diagnostics, and telemedicine adoption are key trends.
1. Introduction 1.1 Report Description 1.2 Research Methodology 1.2.1 Data Mining 1.2.2 Market Modeling and Forecasting 1.2.3 Data Validation 1.2.4 Industry Analysis 2. Market Dashboard 3. Market Overview 3.1 Market Definition and Scope 3.2 Market Segmentation 3.2.1 By Treatment Type 3.2.2 By End-User 3.2.3 By Distribution Channel 3.2.4 By Geography 3.3 Market Dynamics 3.3.1 Drivers 3.3.2 Restraints 3.3.3 Opportunities 3.3.4 Challenges 4. Global ATTR-CM Market by Treatment Type 4.1 Introduction 4.2 Market Size and Growth Rate by Treatment Type (2024-2030) 4.2.1 Pharmacological Therapies 4.2.1.1 Tafamidis 4.2.1.2 Diflunisal 4.2.1.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) 4.2.1.4 Others 4.2.2 Gene Silencing Therapies 4.2.2.1 Patisiran 4.2.2.2 Inotersen 4.2.3 Supportive Therapies 4.2.3.1 Beta-Blockers 4.2.3.2 Diuretics 4.2.3.3 Anti-arrhythmic Drugs 4.2.4 Diagnostics 4.2.4.1 Imaging Techniques 4.2.4.1.1 Echocardiography 4.2.4.1.2 Cardiac MRI 4.2.4.1.3 Nuclear Imaging 4.2.4.1.4 Others 4.2.4.2 Biomarker Testing 4.2.4.2.1 NT-proBNP Testing 4.2.4.2.2 Troponin Testing 4.2.4.2.3 Others 4.2.4.3 Genetic Testing 4.2.4.3.1 Mutation Analysis 4.2.4.3.2 Family History Testing 5. Global ATTR-CM Market by End-User 5.1 Introduction 5.2 Market Size and Growth Rate by End-User (2024-2030) 5.2.1 Hospitals and Clinics 5.2.1.1 Cardiology Departments 5.2.1.2 Specialty Clinics 5.2.2 Diagnostic Laboratories 5.2.2.1 Independent Laboratories 5.2.2.2 Hospital-Affiliated Labs 5.2.3 Research and Academic Institutes 6. Global ATTR-CM Market by Distribution Channel 6.1 Introduction 6.2 Market Size and Growth Rate by Distribution Channel (2024-2030) 6.2.1 Hospital Pharmacies 6.2.1.1 Inpatient Dispensing 6.2.1.2 Specialty Drug Distribution 6.2.2 Retail Pharmacies 6.2.2.1 Chain Pharmacies 6.2.2.2 Standalone Pharmacies 6.2.3 Online Pharmacies 7. Global ATTR-CM Market by Geography 7.1 Introduction 7.2 Market Size and Growth Rate by Region (2024-2030) 7.2.1 North America 7.2.1.1 United States 7.2.1.2 Canada 7.2.2 Europe 7.2.2.1 Germany 7.2.2.2 France 7.2.2.3 United Kingdom 7.2.2.4 Rest of Europe 7.2.3 Asia Pacific 7.2.3.1 China 7.2.3.2 Japan 7.2.3.3 India 7.2.3.4 Southeast Asia 7.2.3.5 Rest of Asia Pacific 7.2.4 Latin America 7.2.4.1 Brazil 7.2.4.2 Rest of Latin America 7.2.5 Middle East & Africa (MEA) 7.2.5.1 GCC 7.2.5.2 North Africa 7.2.5.3 South Africa 7.2.5.4 Rest of Middle East & Africa
8. Competitive Landscape 8.1 Company Profiles 8.1.1 Pfizer Inc. (United States) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 8.1.2 Alnylam Pharmaceuticals (United States) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 8.1.3 Eidos Therapeutics (United States) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 8.1.4 Ionis Pharmaceuticals (United States) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 8.1.5 BridgeBio Pharma (United States) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 8.1.6 AstraZeneca (United Kingdom) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 8.1.7 GlaxoSmithKline (United Kingdom) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 8.1.8 Johnson & Johnson (United States) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 8.1.9 Novartis AG (Switzerland) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 8.1.10 Sanofi (France) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 8.1.11 Prothena Corporation (United States) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 8.1.12 Regeneron Pharmaceuticals (United States) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 8.1.13 Merck & Co. (United States) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 8.1.14 Amgen Inc. (United States) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 8.1.15 Bristol-Myers Squibb (United States) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 9. List of Tables and Figure Tables Table Global ATTR-CM Market Size by Treatment Type (2024-2030) Table Pharmacological Therapies Market Size by Sub-type (2024-2030) Table Gene Silencing Therapies Market Size by Sub-type (2024-2030) Table Supportive Therapies Market Size by Sub-type (2024-2030) Table Diagnostics Market Size by Sub-type (2024-2030) Table Imaging Techniques Market Size by Sub-type (2024-2030) Table Biomarker Testing Market Size by Sub-type (2024-2030) Table Genetic Testing Market Size by Sub-type (2024-2030) Table Global ATTR-CM Market Size by End-User (2024-2030) Table Hospitals and Clinics Market Size by Sub-type (2024-2030) Table Diagnostic Laboratories Market Size by Sub-type (2024-2030) Table Global ATTR-CM Market Size by Distribution Channel (2024-2030) Table Hospital Pharmacies Market Size by Sub-type (2024-2030) Table Retail Pharmacies Market Size by Sub-type (2024-2030) Figures Figure Global ATTR-CM Market Size and Growth Rate by Treatment Type (2024-2030) Figure Pharmacological Therapies Market Growth Rate by Sub-type (2024-2030) Figure Gene Silencing Therapies Market Growth Rate by Sub-type (2024-2030) Figure Supportive Therapies Market Growth Rate by Sub-type (2024-2030) Figure Diagnostics Market Growth Rate by Sub-type (2024-2030) Figure Imaging Techniques Market Growth Rate by Sub-type (2024-2030) Figure Biomarker Testing Market Growth Rate by Sub-type (2024-2030) Figure Genetic Testing Market Growth Rate by Sub-type (2024-2030) Figure Global ATTR-CM Market Size and Growth Rate by End-User (2024-2030) Figure Global ATTR-CM Market Size and Growth Rate by Distribution Channel (2024-2030) Table Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Regions (2022-2024) Table Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Regions (2024-2030) Figure North America Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Size and Growth Rate (2024-2030) Table North America Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2022-2024) Table North America Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2024-2030) Table North America Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2022-2024) Table North America Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2024-2030) Table North America Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2022-2024) Table North America Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2024-2030) Table North America Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2022-2024) Table North America Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2024-2030) Table North America Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Country (2022-2024) Table North America Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Country (2024-2030) Figure United States Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Size and Growth Rate (2024-2030) Table United States Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2022-2024) Table United States Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2024-2030) Table United States Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2022-2024) Table United States Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2024-2030) Table United States Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2022-2024) Table United States Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2024-2030) Table United States Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2022-2024) Table United States Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2024-2030) Figure Canada Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Size and Growth Rate (2024-2030) Table Canada Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2022-2024) Table Canada Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2024-2030) Table Canada Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2022-2024) Table Canada Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2024-2030) Table Canada Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2022-2024) Table Canada Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2024-2030) Table Canada Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2022-2024) Table Canada Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2024-2030) Figure Europe Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Size and Growth Rate (2024-2030) Table Europe Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2022-2024) Table Europe Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2024-2030) Table Europe Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2022-2024) Table Europe Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2024-2030) Table Europe Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2022-2024) Table Europe Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2024-2030) Table Europe Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2022-2024) Table Europe Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2024-2030) Table Europe Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Country (2022-2024) Table Europe Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Country (2024-2030) Figure Germany Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Size and Growth Rate (2024-2030) Table Germany Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2022-2024) Table Germany Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2024-2030) Table Germany Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2022-2024) Table Germany Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2024-2030) Table Germany Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2022-2024) Table Germany Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2024-2030) Table Germany Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2022-2024) Table Germany Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2024-2030) Figure France Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Size and Growth Rate (2024-2030) Table France Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2022-2024) Table France Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2024-2030) Table France Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2022-2024) Table France Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2024-2030) Table France Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2022-2024) Table France Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2024-2030) Table France Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2022-2024) Table France Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2024-2030) Figure United Kingdom UK Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Size and Growth Rate (2024-2030) Table United Kingdom UK Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2022-2024) Table United Kingdom UK Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2024-2030) Table United Kingdom UK Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2022-2024) Table United Kingdom UK Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2024-2030) Table United Kingdom UK Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2022-2024) Table United Kingdom UK Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2024-2030) Table United Kingdom UK Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2022-2024) Table United Kingdom UK Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2024-2030) Figure Russia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Size and Growth Rate (2024-2030) Table Russia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2022-2024) Table Russia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2024-2030) Table Russia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2022-2024) Table Russia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2024-2030) Table Russia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2022-2024) Table Russia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2024-2030) Table Russia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2022-2024) Table Russia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2024-2030) Figure Italy Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Size and Growth Rate (2024-2030) Table Italy Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2022-2024) Table Italy Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2024-2030) Table Italy Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2022-2024) Table Italy Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2024-2030) Table Italy Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2022-2024) Table Italy Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2024-2030) Table Italy Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2022-2024) Table Italy Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2024-2030) Figure Rest of Europe Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Size and Growth Rate (2024-2030) Table Rest of Europe Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2022-2024) Table Rest of Europe Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2024-2030) Table Rest of Europe Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2022-2024) Table Rest of Europe Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2024-2030) Table Rest of Europe Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2022-2024) Table Rest of Europe Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2024-2030) Table Rest of Europe Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2022-2024) Table Rest of Europe Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2024-2030) Figure Asia-Pacific Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Size and Growth Rate (2024-2030) Table Asia-Pacific Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2022-2024) Table Asia-Pacific Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2024-2030) Table Asia-Pacific Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2022-2024) Table Asia-Pacific Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2024-2030) Table Asia-Pacific Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2022-2024) Table Asia-Pacific Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2024-2030) Table Asia-Pacific Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2022-2024) Table Asia-Pacific Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2024-2030) Table Asia-Pacific Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Country (2022-2024) Table Asia-Pacific Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Country (2024-2030) Figure China Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Size and Growth Rate (2024-2030) Table China Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2022-2024) Table China Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2024-2030) Table China Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2022-2024) Table China Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2024-2030) Table China Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2022-2024) Table China Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2024-2030) Table China Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2022-2024) Table China Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2024-2030) Figure Japan Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Size and Growth Rate (2024-2030) Table Japan Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2022-2024) Table Japan Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2024-2030) Table Japan Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2022-2024) Table Japan Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2024-2030) Table Japan Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2022-2024) Table Japan Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2024-2030) Table Japan Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2022-2024) Table Japan Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2024-2030) Figure Korea Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Size and Growth Rate (2024-2030) Table Korea Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2022-2024) Table Korea Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2024-2030) Table Korea Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2022-2024) Table Korea Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2024-2030) Table Korea Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2022-2024) Table Korea Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2024-2030) Table Korea Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2022-2024) Table Korea Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2024-2030) Figure India Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Size and Growth Rate (2024-2030) Table India Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2022-2024) Table India Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2024-2030) Table India Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2022-2024) Table India Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2024-2030) Table India Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2022-2024) Table India Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2024-2030) Table India Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2022-2024) Table India Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2024-2030) Figure Southeast Asia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Size and Growth Rate (2024-2030) Table Southeast Asia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2022-2024) Table Southeast Asia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2024-2030) Table Southeast Asia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2022-2024) Table Southeast Asia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2024-2030) Table Southeast Asia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2022-2024) Table Southeast Asia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2024-2030) Table Southeast Asia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2022-2024) Table Southeast Asia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2024-2030) Figure Rest of Asia-Pacific Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Size and Growth Rate (2024-2030) Table Rest of Asia-Pacific Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2022-2024) Table Rest of Asia-Pacific Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2024-2030) Table Rest of Asia-Pacific Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2022-2024) Table Rest of Asia-Pacific Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2024-2030) Table Rest of Asia-Pacific Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2022-2024) Table Rest of Asia-Pacific Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2024-2030) Table Rest of Asia-Pacific Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2022-2024) Table Rest of Asia-Pacific Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2024-2030) Figure Latin America Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Size and Growth Rate (2024-2030) Table Latin America Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2022-2024) Table Latin America Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2024-2030) Table Latin America Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2022-2024) Table Latin America Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2024-2030) Table Latin America Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2022-2024) Table Latin America Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2024-2030) Table Latin America Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2022-2024) Table Latin America Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2024-2030) Table Latin America Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Country (2022-2024) Table Latin America Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Country (2024-2030) Figure Brazil Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Size and Growth Rate (2024-2030) Table Brazil Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2022-2024) Table Brazil Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2024-2030) Table Brazil Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2022-2024) Table Brazil Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2024-2030) Table Brazil Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2022-2024) Table Brazil Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2024-2030) Table Brazil Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2022-2024) Table Brazil Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2024-2030) Figure Mexico Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Size and Growth Rate (2024-2030) Table Mexico Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2022-2024) Table Mexico Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2024-2030) Table Mexico Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2022-2024) Table Mexico Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2024-2030) Table Mexico Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2022-2024) Table Mexico Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2024-2030) Table Mexico Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2022-2024) Table Mexico Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2024-2030) Figure Columbia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Size and Growth Rate (2024-2030) Table Columbia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2022-2024) Table Columbia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2024-2030) Table Columbia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2022-2024) Table Columbia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2024-2030) Table Columbia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2022-2024) Table Columbia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2024-2030) Table Columbia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2022-2024) Table Columbia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2024-2030) Figure Rest of Latin America Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Size and Growth Rate (2024-2030) Table Rest of Latin America Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2022-2024) Table Rest of Latin America Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2024-2030) Table Rest of Latin America Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2022-2024) Table Rest of Latin America Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2024-2030) Table Rest of Latin America Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2022-2024) Table Rest of Latin America Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2024-2030) Table Rest of Latin America Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2022-2024) Table Rest of Latin America Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2024-2030) Figure Middle East and Africa Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Size and Growth Rate (2024-2030) Table Middle East and Africa Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2022-2024) Table Middle East and Africa Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2024-2030) Table Middle East and Africa Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2022-2024) Table Middle East and Africa Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2024-2030) Table Middle East and Africa Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2022-2024) Table Middle East and Africa Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2024-2030) Table Middle East and Africa Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2022-2024) Table Middle East and Africa Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2022-2024) Table Middle East and Africa Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2024-2030) Table Middle East and Africa Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Country (2024-2030) Figure Saudi Arabia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Size and Growth Rate (2024-2030) Table Saudi Arabia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2022-2024) Table Saudi Arabia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2024-2030) Table Saudi Arabia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2022-2024) Table Saudi Arabia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2024-2030) Table Saudi Arabia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2022-2024) Table Saudi Arabia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2024-2030) Table Saudi Arabia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2022-2024) Table Saudi Arabia Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2024-2030) Figure United Arab Emirates Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Size and Growth Rate (2024-2030) Table United Arab Emirates Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2022-2024) Table United Arab Emirates Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2024-2030) Table United Arab Emirates Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2022-2024) Table United Arab Emirates Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2024-2030) Table United Arab Emirates Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2022-2024) Table United Arab Emirates Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2024-2030) Table United Arab Emirates Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2022-2024) Table United Arab Emirates Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2024-2030) Figure South Africa Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Size and Growth Rate (2024-2030) Table South Africa Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2022-2024) Table South Africa Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2024-2030) Table South Africa Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2022-2024) Table South Africa Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2024-2030) Table South Africa Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2022-2024) Table South Africa Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2024-2030) Table South Africa Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2022-2024) Table South Africa Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2024-2030) Figure Rest of Middle East and Africa Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Size and Growth Rate (2024-2030) Table Rest of Middle East and Africa Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2022-2024) Table Rest of Middle East and Africa Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by By Treatment Type(2024-2030) Table Rest of Middle East and Africa Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2022-2024) Table Rest of Middle East and Africa Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Diagnostic (2024-2030) Table Rest of Middle East and Africa Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2022-2024) Table Rest of Middle East and Africa Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by End User (2024-2030) Table Rest of Middle East and Africa Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2022-2024) Table Rest of Middle East and Africa Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market by Distribution Channel (2024-2030)
The process of market research at Ultra Market Research is an iterative in application and usually follows following path. Information from secondary used to build data models, then results from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done and new Information is again incorporated into data model. The process continues till desired level of Information is not generated
To calculate the market size, the report considers the revenue generated from the sales of Ultra Market Research providers. The revenue generated from the sales of Ultra Market Research has been calculated through primary and secondary research. The report also presents the key players operating in the Ultra Market Research market across the globe identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes distribution channel segmentation determined using secondary sources and verified through primary sources.
Secondary Research
The secondary research source that are typically referred to include, but are not limited to:
Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
Internal and external proprietary databases, relevant patent and regulatory databases
National government documents, statistical databases and market reports
News articles, press releases and web-casts specific to the companies operating in the market
The source for secondary research includes but is not limited to: Factiva, Hoovers and Statista
Inner Circle Represents – Stage of Research Process
Middle Circle Represents – Source of Information
Outer Circle Represents – Information Derived from that source
Primary Research We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:
It provides first-hand Information on the market size, market trends, growth trends, competitive landscape, future outlook etc.
Helps in validating and strengthening the secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies
The participants who typically take part in such a process include, but are not limited to:
Industry participants: CEOs, VPs, marketing/ distribution channel managers, market intelligence managers and national sales managers
Purchasing managers, technical personnel, distributors and resellers
Outside experts: Investment bankers, valuation experts, research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry distribution channels
Models Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data distribution channels to produce estimates:
Demographic data: Population split by segment
Macro-economic indicators: GDP, etc.
Industry indicators: Expenditure, distribution channel stage & infrastructure, sector growth and facilities.
Data is then cross checked by the expert panel.
2..1 Company Share Analysis Model
Company share analysis is used to derive the size of Global market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps: 2..2 Revenue Based Modeling
Revenue based models can be built in two ways – Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.
2.1 Research Limitations Inflation is not a part of pricing in this report. Prices of Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market and its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each distribution channel has been taken into account while estimating and forecasting market revenue Globally. Regional average price has been considered while breaking down this market by application in each region. This report provides market size of Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market for the past year and forecasts for the next six years. Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market. Market size is given in terms of revenue. Market revenue is defined in USD Million. Market numbers are given on the basis of different Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market categories. Market size and forecasts for each major application is provided in the context of Global market. The numbers provided in this report are derived on the basis of demand for Global Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market from different application industries in different regions.
Segmentation
By Treatment Type
Pharmacological Therapies
Tafamidis
Diflunisal
Non-steroidal anti-inflammatory Drugs (NSAIDs)
Others
Gene Silencing Therapies
Patisiran
Inotersen
Supportive Therapies
Beta-Blockers
Diuretics
Anti-arrhythmic Drugs
By Diagnostics
Imaging Techniques
Echocardiography
Cardiac MRI
Nuclear Imaging
Others
Biomarker Testing
NT-proBNP Testing
Troponin Testing
Others
Genetic Testing
Mutation Analysis
Family History Testing
By End-User
Hospitals and Clinics
Cardiology Departments
Specialty Clinics
Diagnostic Laboratories
Independent Laboratories
Hospital-Affiliated Labs
Research and Academic Institutes
By Distribution Channel
Hospital Pharmacies
Inpatient Dispensing
Specialty Drug Distribution
Retail Pharmacies
Chain Pharmacies
Standalone Pharmacies
Online Pharmacies
By Geography
North America United States Canada
Europe Germany France United Kingdom
Rest of Europe
Asia Pacific China Japan India
Southeast Asia Rest of Asia Pacific
Latin America Brazil Rest of Latin America
Middle East & Africa (MEA) GCC North Africa South Africa Rest of Middle East & Africa
